Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Diabetes drug semaglutide linked to reduced risk of dementia in type 2 diabetes patients Effects strongest in women and older ...

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...

People with type 2 diabetes who used semaglutide (Ozempic) versus other drugs had a lower risk of Alzheimer's disease and related dementia, especially vascular dementia, electronic health records ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

This is just one of a growing list of diseases and conditions Ozempic has been ... Two new studies out today have linked the use of GLP-1 drugs to a lower dementia risk. New Africa ...

Well, this is just one study, so it’s hard to say for sure that Ozempic will lower your risk for dementia. But a 2024 study published in the journal Alzheimer’s & Dementia also linked these ...

Ozempic Linked With Lower Dementia Risk, Nicotine Use, British Study Finds. More. Reuters. FILE PHOTO: A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31 ...

Ozempic and similar novel diabetes treatments may lower the risk of Alzheimer's disease and related dementias.. This is the conclusion of a pair of studies by research teams from the U.S. and ...